Results 151 to 160 of about 27,341 (230)

Implications for ezetimibe therapy use based on IMPROVE-IT criteria

, 2015
Purpose: In the IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT), simvastatin/ezetimibe combination was associated with a 6% relative risk reduction in the combined cardiovascular outcome compared with simvastatin alone ...
Petersen, Laura A, Virani, Salim S., Ballantyne, Christie M, Maddo, Thomas M, Gillette, Michael A, Rumsfeld, John, Akeroyd, Julia M, Ho, P Michael, Nambi, Vijay   +8 more
core  

Pilot study of the use of ezetimibe in dogs with hyperlipidemia. [PDF]

Vet Res Commun
de Lima Wachholz P, Bierhals ES, de Lima CM, Grala CX, de Freitas VR, Jorge S, Bruhn FRP, de Oliveira Nobre M, Rondelli MCH.   +8 more
europepmc   +1 more source

A Comprehensive, Updated Review of Ezetimibe: Evidence-Based Clinical Use for Atherosclerotic Cardiovascular Disease. [PDF]

Am J Cardiovasc Drugs
Liu HH, Liu ZH, Chen SS, Zhu CG, Li JJ.
europepmc   +1 more source

Serious drug-induced liver disease secondary to ezetimibe

Ezetimibe is the first member of a new family of lipid-lowering drugs that inhibits uptake of dietary and biliary cholesterol. It was approved by the FDA in 2002 for hypercholesterolemia alone or in combination with statins.
Girbau, Anna, Castellote Alonso, José, Ariza Cardenal, Javier, Xiol Quingles, Xavier, Rota, Rosa   +4 more
core   +1 more source

Cost-utility analysis of add-on ezetimibe to moderate-intensity statin versus moderate-intensity statin alone for secondary prevention in patients with acute coronary syndrome intolerant to high-intensity statin therapy in Thailand. [PDF]

Front Pharmacol
Promchit N, Chinwong S, Permsuwan U.
europepmc   +1 more source

Early escalation of oral lipid-lowering therapy to achieve LDL-cholesterol targets in patients after myocardial infarction: study protocol for the prospective, open-label HAnnover ChOlesterol Lowering in Acute Coronary Syndrome trial. [PDF]

Front Cardiovasc Med
Schäfer A, Großhennig A, Theis L, Schindler C, Grahl E, Stichtenoth DO, König T, Geller WA, Schmidt HHJG, Bavendiek U, Bauersachs J.   +10 more
europepmc   +1 more source

Real-World Safety and Efficacy of a Pitavastatin-Ezetimibe Combination Therapy in Taiwanese Patients after PCI. [PDF]

Acta Cardiol Sin
Lu YW, Fang CC, Cheng YT.
europepmc   +1 more source

Combination therapy with moderate-intensity statins and ezetimibe and risk of incident PCI/CABG in atherosclerotic cardiovascular disease: a propensity-matched cohort study. [PDF]

Lancet Reg Health West Pac
He H, Tang J, Yan VKC, Blais JE, Wong CK, Tam MTK, Yiu HHE, Tse HF, Chan EWY.   +8 more
europepmc   +1 more source

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

New England Journal of Medicine, 2008
A. Rossebø, T. Pedersen, K. Boman, P. Brudi, J. Chambers, K. Egstrup, E. Gerdts, C. Gohlke-Bärwolf, I. Holme, Y. Kesäniemi, W. Malbecq, C. Nienaber, S. Ray, T. Skjærpe, K. Wachtell, R. Willenheimer   +15 more
semanticscholar   +1 more source

Ezetimibe Normalizes Dietary Cholesterol-Induced Exacerbation of Liver Injury in Alcohol-Fed Mice. [PDF]

Biomolecules
Xu Y, Zhang N, Wickramasinghe PB, Veera K, Parupalli P, Dao A, Liu J, Anand R, Langley LE, Eadha S, Iqbal H, Liu C, Bian F, Jia L.   +13 more
europepmc   +1 more source